Success Metrics

Clinical Success Rate

87.5%

Based on 7 completed trials

Completion Rate

88%(7/8)

Active Trials

1(5%)

Results Posted

14%(1 trials)

Terminated

1(5%)

Phase Distribution

Ph phase_2

11%

Ph not_applicable

42%

Ph phase_1

32%

Ph phase_3

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution17 total trials

Phase 1Safety & dosage

6(35.3%)

Phase 2Efficacy & side effects

2(11.8%)

Phase 3Large-scale testing

1(5.9%)

N/ANon-phased studies

8(47.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(7)

Terminated(3)

Other(7)

Detailed Status

Completed7

unknown7

Withdrawn2

Not yet recruiting1

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

87.5%

Most Advanced

Phase 3

Trials by Phase

Phase 16 (35.3%)

Phase 22 (11.8%)

Phase 31 (5.9%)

N/A8 (47.1%)

Trials by Status

completed737%

not_yet_recruiting15%

recruiting15%

terminated15%

unknown737%

withdrawn211%

Recent Activity

1 active trials

Showing 5 of 19

not_yet_recruitingphase_2

Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia

NCT03378414

completednot_applicable

Separate and Combined Extrapancreatic Effects of GIP and GLP-1

NCT06895408

completednot_applicable

Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery

NCT06490718

completed

Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors

NCT04064294

recruiting

Optimizing Treatment on Idiopathic Inflammatory Myopathies

NCT03092180

View all 19 trials

Clinical Trials (19)

Showing 19 of 19 trials

NCT03378414Phase 2

Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia

Not Yet Recruiting

NCT06895408Not Applicable

Separate and Combined Extrapancreatic Effects of GIP and GLP-1

Completed

NCT06490718Not Applicable

Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery

Completed

NCT04064294

Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors

Completed

NCT03092180

Optimizing Treatment on Idiopathic Inflammatory Myopathies

Recruiting

NCT05595395Not Applicable

The Enteral Resuscitation In Intensive Care Pilot- Study

Unknown

NCT05053308Not Applicable

Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement

Withdrawn

NCT05177653Not Applicable

Separate and Combined Extrapancreatic Effects of the Incretin Hormones

Completed

NCT03417401Phase 1

Surgical Stabilizer Assisted RVC With rtPA for CRVO

Withdrawn

NCT05524194Phase 1

6MW3511 in Patients With Advanced Solid Tumor

Unknown

NCT05048160Phase 1

A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm

Unknown

NCT05204784Not Applicable

Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis

Unknown

NCT04814745Not Applicable

Intrathecal Morphine for Radical Robot Assisted Prostatectomy (TORNADO)

Completed

NCT03790176Phase 1

ZAVI APD ELF Protocol v2.2

Unknown

NCT04767542Phase 3

Postoperative Pain Difference for 'IV Paracetamol' and TAP Block' in Acute Cholecystitis

Unknown

NCT04656886Not Applicable

Ketamine's Actions on Rumination Mechanisms as an Antidepressant

Completed

NCT04002427Phase 1

Mass Balance Recovery, Pharmacokinetics and Metabolite Profile and Identification of [14C]AZD7594

Completed

NCT03604796Phase 2

Alternative Paracetamol Treatments for the Neonate With a hsPDA

Unknown

NCT02562820Phase 1

An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome

Terminated

All 19 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 19